UB Paderborn / Katalog / Suche / in CDI

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.209-219

2018

Volltextzugriff (PDF)

Pre‐analytical issues in the measurement of circulating microparticles: current recommendations and pending questions

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.693-696

2013

Volltextzugriff (PDF)

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Thrombosis journal, 2020-09, Vol.18 (1), p.17-16, Article 17

2020

Volltextzugriff (PDF)

Evaluation of the analytical performances of FibWave, a new sensitive tool assessing the fibrin clot formation, to measure the effects of anticoagulants

Thrombosis research, 2020-07, Vol.191, p.78-81

2020

Volltextzugriff (PDF)

Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1166-1168

2015

Volltextzugriff (PDF)

Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsus

Journal of thrombosis and haemostasis, 2017-03, Vol.15 (3), p.487-499

2017

Volltextzugriff (PDF)

Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosis

Thrombosis research, 2014-06, Vol.133 (6), p.1068-1073

2014

Volltextzugriff (PDF)

More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry‐based quantification of biological microparticles

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1679-1681

2011

Volltextzugriff (PDF)

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry

Thrombosis research, 2014-06, Vol.133 (6), p.1074-1078

2014

Volltextzugriff (PDF)

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

Thrombosis research, 2013-09, Vol.132 (3), p.352-359

2013

Volltextzugriff (PDF)

Limited inflammatory response in rats after acute exposure to a silicon carbide nanoaerosol

Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 2015-08, Vol.17 (8), p.1-15, Article 346

2015

Volltextzugriff (PDF)

The use of PIXE for engineered nanomaterials quantification in complex matrices

Journal of physics. Conference series, 2013-01, Vol.429 (1), p.12010-8

2013

Volltextzugriff (PDF)

How does the deposited dose of oxide nanomaterials evolve in an in vitro assay?

Journal of physics. Conference series, 2013-01, Vol.429 (1), p.12013-10

2013

Volltextzugriff (PDF)

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

Thrombosis and haemostasis, 2013-09, Vol.110 (3), p.543

2013

Volltextzugriff (PDF)

What is the impact of Silicon Carbide nanoparticles to the mineral composition of rat lungs? A PIXE-μPIXE comparative study

Journal of physics. Conference series, 2015-05, Vol.617 (1), p.12016

2015

Volltextzugriff (PDF)

The impact of instilled carbide nanoparticles on rat lungs: an in vivo perspective on acute intratracheal instillation

Journal of physics. Conference series, 2015-05, Vol.617 (1), p.12017

2015

Volltextzugriff (PDF)

Bioactivity and hemocompatibility study of amorphous hydrogenated carbon coatings produced by pulsed magnetron discharge

Journal of biomedical materials research. Part A, 2013-06, Vol.101A (6), p.1800-1812

2013

Volltextzugriff (PDF)

Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation

Prostaglandins, leukotrienes and essential fatty acids, 2003, Vol.68 (1), p.55-59

2003

Volltextzugriff (PDF)

Confirmation of high cytokine clearance by hemofiltration with a cellulose triacetate membrane with large pores: an in vivo study

International journal of artificial organs, 2006-10, Vol.29 (10), p.944-948

2006

Volltextzugriff (PDF)

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Thrombosis and haemostasis, 2013-08, Vol.110 (2), p.283

2013

Volltextzugriff (PDF)

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Thrombosis and haemostasis, 2013-10, Vol.110 (4), p.723

2013

Volltextzugriff (PDF)

Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model

European journal of obstetrics & gynecology and reproductive biology, 2024-02, Vol.293, p.125

2024

Volltextzugriff (PDF)

The mirages of the new oral anticoagulants

Journal de pharmacie de Belgique, 2014-03 (1), p.38

2014

Volltextzugriff (PDF)

New trends in dual 5-LOX/COX inhibition

Current medicinal chemistry, 2002-05, Vol.9 (9), p.941

2002

Volltextzugriff (PDF)

Effects of U-46619 on Pulmonary Hemodynamics Before and After Administration of BM-573, a Novel Thromboxane A2 Inhibitor

Archives of physiology and biochemistry, 2003-07, Vol.111 (3), p.217-223

2003

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Pre‐analytical issues in the measurement of circulating microparticles: current recommendations and pending questions

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Evaluation of the analytical performances of FibWave, a new sensitive tool assessing the fibrin clot formation, to measure the effects of anticoagulants

Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment

Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsus

Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosis

More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry‐based quantification of biological microparticles

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

Limited inflammatory response in rats after acute exposure to a silicon carbide nanoaerosol

The use of PIXE for engineered nanomaterials quantification in complex matrices

How does the deposited dose of oxide nanomaterials evolve in an in vitro assay?

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

What is the impact of Silicon Carbide nanoparticles to the mineral composition of rat lungs? A PIXE-μPIXE comparative study

The impact of instilled carbide nanoparticles on rat lungs: an in vivo perspective on acute intratracheal instillation

Bioactivity and hemocompatibility study of amorphous hydrogenated carbon coatings produced by pulsed magnetron discharge

Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation

Confirmation of high cytokine clearance by hemofiltration with a cellulose triacetate membrane with large pores: an in vivo study

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model

The mirages of the new oral anticoagulants

New trends in dual 5-LOX/COX inhibition

Effects of U-46619 on Pulmonary Hemodynamics Before and After Administration of BM-573, a Novel Thromboxane A2 Inhibitor

Suchergebnisse filtern